Down’s syndrome is one of the most common chromosomal abnormalities, that presents a spectrum of physical, developmental, ...

These types of mistakes are often described as “never events,” a term first coined in 2002 to refer to preventable medical ...

Exagen (XGN) is a speculative buy with promising growth in diagnostics, new lupus/RA tests, and potential positive EBITDA by ...

To check testosterone levels, book a serum testosterone test through Apollo 24|7, a reliable diagnostic lab—preferably for ...

Brianna Abbott is a health reporter covering the treatment and prevention of disease, with a special focus on cancer, in The Wall Street Journal’s Health and Science bureau.

Enitan Odeyemi, Director, Business Development, Codix Pharma Ltd; Mary Ogangwu - Chief Operating Officer, Codix Pharma Ltd; Kingsley Aguoru - Chief Operating Officer, Colexa Biosensor Ltd; Olanrewaju ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced new clinical data will be shared at the American Association for Cancer Research (AACR) ...

A new strategy for tuberculosis (TB) screening provides a solution to problems with current TB screening, which does not always accurately detect disease. Simultaneously screening for both active and ...

DELFI Diagnostics has clinically validated FirstLook Lung, its blood test designed to improve early detection of lung cancer, which remains the leading cause of cancer deaths in the United States. At ...

A number of the Dutch firm's products have received certification under Europe's In Vitro Diagnostic Regulation recently.

EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation from the FDA.